Sibilia Quilici | Executive Director
Vaccines Europe

Sibilia Quilici, Executive Director, Vaccines Europe

Sibilia Quilici joined Vaccines Europe as Executive Director in January 2021. Vaccines Europe  (VE) represents major innovative research-based vaccine companies operating in Europe, including small and medium-sized enterprises. Together with its direct membership of 14 leading vaccine companies and a network of 24 National Vaccine Industry Groups across Europe, Vaccines Europe’s mission is to “foster innovation & value recognition of lifecourse immunisation in Europe to protect people against evolving health challenges”.  Sibilia holds an International MBA in entrepreneurship and MSc in Health Economics and biostatistics. With more than 15 years of experience in working for the vaccine industry, she holds a track record in studies valuing the full benefits of preventative measures (such as vaccines), from a micro and macro socio-medico-economic perspective, addressing all relevant stakeholder concerns (supra-national institutions, governments, industry, society, healthcare professionals and citizens). 


Day 1 - Tuesday 29th October @ 17:00

Can uptake keep up with the speed of vaccine developments?

-      Closing the uptake gap between child and adult immunisation

-      Current uptake issues: why is measles coming back and what can we do?

-      The importance of RWE, data & management in immunisation programmes

-      With 100+ vaccines in the pipeline; what are the realities for uptake and implementation?

-      Case studies from countries with high uptake of seasonal vaccines

last published: 10/Jul/24 14:15 GMT

back to speakers